AdvaMedDx: Thierry Bernard, Norman Schwartz

Mar 30, 2023

AdvaMedDx has named Qiagen CEO Thierry Bernard as chairperson of the board of directors, succeeding Bio-Rad Laboratories CEO Norman Schwartz. AdvaMed represents more than 75 manufacturers of in vitro diagnostic tests and technologies in the US and abroad. Bernard joined Qiagen in 2015 and has served as CEO since 2019. He previously held executive positions at BioMérieux.

Breaking News

Large Study of Early-Onset Colorectal Cancer Patients IDs Unique, Potentially Actionable Mutations
New Primate Genomes Study Deepens Understanding of Humans
People in the News at Illumina, Pacific Biosciences, Myriad Genetics, Delfi Diagnostics, More
New Products Posted to GenomeWeb: LabCorp, BostonGene, Seer, Myriad Genetics, More
Owkin, NanoString Technologies Launch $50M Spatial Omics Research Program for Cancer Research

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.